Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.625
-0.065 (-3.85%)
Nov 21, 2024, 12:28 PM EST - Market open
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 208 employees as of December 31, 2023. The number of employees increased by 11 or 5.58% compared to the previous year.
Employees
208
Change (1Y)
11
Growth (1Y)
5.58%
Revenue / Employee
$219,553
Profits / Employee
-$46,183
Market Cap
119.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
Seres Therapeutics | 233 |
Repare Therapeutics | 179 |
Rani Therapeutics Holdings | 140 |
Vigil Neuroscience | 69 |
Milestone Pharmaceuticals | 47 |
Fennec Pharmaceuticals | 29 |
Outlook Therapeutics | 24 |
PLX News
- 7 days ago - Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results - PRNewsWire
- 14 days ago - Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024 - PRNewsWire
- 27 days ago - Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 - PRNewsWire
- 2 months ago - Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm - Business Wire
- 2 months ago - Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024 - GlobeNewsWire
- 2 months ago - Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes - PRNewsWire